{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T03:08:54Z","timestamp":1770692934176,"version":"3.49.0"},"reference-count":94,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.lfs.2025.123637","type":"journal-article","created":{"date-parts":[[2025,4,24]],"date-time":"2025-04-24T07:53:31Z","timestamp":1745481211000},"page":"123637","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["A review of the human microRNA and the Mycobacterium tuberculosis epigenetic effects on the emergence drug resistance"],"prefix":"10.1016","volume":"374","author":[{"given":"Yashna","family":"Sukdeo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nozibusiso Pearl","family":"Shozi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nonsikelelo","family":"Ndimande","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kingsley Chimaeze","family":"Mbara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter M.O.","family":"Owira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.lfs.2025.123637_bb0005","series-title":"Global tuberculosis report 2024 Geneva","author":"World Health Organization","year":"2024"},{"issue":"5","key":"10.1016\/j.lfs.2025.123637_bb0010","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1093\/jac\/dkx506","article-title":"Evolution of drug resistance in Mycobacterium tuberculosis: a review on the molecular determinants of and implications for personalised care","volume":"73","author":"Dookie","year":"2018","journal-title":"J. Antimicrob. Chemother."},{"issue":"6","key":"10.1016\/j.lfs.2025.123637_bb0015","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/j.cmi.2023.02.013","article-title":"Long-term treatment outcomes in patients with multidrug-resistant tuberculosis","volume":"29","author":"Maier","year":"2023","journal-title":"Clin. Microbiol. Infect."},{"key":"10.1016\/j.lfs.2025.123637_bb0020","article-title":"Psychosocial support interventions to improve treatment outcomes for people living with tuberculosis: a mixed methods systematic review and meta-analysis","volume":"61","author":"Maynard","year":"2023","journal-title":"eClinical Medicine."},{"key":"10.1016\/j.lfs.2025.123637_bb0025","series-title":"Psychosocial Support for People with TB, HIV and Viral Hepatitis in the Continuum of Care in the WHO European Region","author":"World Health Organization","year":"2020"},{"key":"10.1016\/j.lfs.2025.123637_bb0030","first-page":"18","article-title":"The epigenome","volume":"1","author":"Waddington","year":"1942","journal-title":"Endevor"},{"issue":"7","key":"10.1016\/j.lfs.2025.123637_bb0035","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1101\/gad.1787609","article-title":"An operational definition of epigenetics","volume":"23","author":"Berger","year":"2009","journal-title":"Genes Dev."},{"key":"10.1016\/j.lfs.2025.123637_bb0040","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1186\/s13148-022-01315-6","article-title":"A critical appraisal of clinical epigenetics","volume":"14","author":"Horsthemke","year":"2022","journal-title":"Clin. Epigenetics"},{"issue":"3","key":"10.1016\/j.lfs.2025.123637_bb0045","doi-asserted-by":"crossref","first-page":"evae029","DOI":"10.1093\/gbe\/evae029","article-title":"Nucleosomes at the dawn of eukaryotes","volume":"16","author":"Hocher","year":"2024","journal-title":"Genome Biol. Evol."},{"key":"10.1016\/j.lfs.2025.123637_bb0050","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s10557-011-6290-z","article-title":"An introduction to small non-coding RNAs: miRNA and snoRNA","volume":"25","author":"Holley","year":"2011","journal-title":"Cardiovas. Drugs Ther."},{"issue":"5","key":"10.1016\/j.lfs.2025.123637_bb0055","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/0092-8674(93)90529-Y","article-title":"The C. Elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14","volume":"75","author":"Lee","year":"1993","journal-title":"Cell"},{"issue":"10","key":"10.1016\/j.lfs.2025.123637_bb0060","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.tcb.2008.07.007","article-title":"The let-7 family of microRNAs","volume":"18","author":"Roush","year":"2008","journal-title":"Trends Cell Biol."},{"issue":"8","key":"10.1016\/j.lfs.2025.123637_bb0065","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1038\/nrm3838","article-title":"Regulation of microRNA biogenesis","volume":"15","author":"Ha","year":"2014","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.lfs.2025.123637_bb0070","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.tube.2019.04.002","article-title":"Host and MTB genome encoded miRNA markers for diagnosis of tuberculosis","volume":"116","author":"Chakrabarty","year":"2019","journal-title":"Tuberculosis"},{"key":"10.1016\/j.lfs.2025.123637_bb0075","series-title":"Guidelines for the Treatment of Drug-Susceptible Tuberculosis and Patient Care, 2017 Update","author":"World Health Organization","year":"2017"},{"key":"10.1016\/j.lfs.2025.123637_bb0080","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1056\/NEJMc2404644","article-title":"Transmission as a key driver of resistance to the new tuberculosis drugs","volume":"392","author":"Goig","year":"2025","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.lfs.2025.123637_bb0085","article-title":"Multidrug resistant tuberculosis and extensively drug-resistant tuberculosis","volume":"5","author":"Seung","year":"2015","journal-title":"Cold Spring Harb. Prospect. Med."},{"key":"10.1016\/j.lfs.2025.123637_bb0090","series-title":"WHO Consolidated Guidelines on Drug-Resistant Tuberculosis Treatment","year":"2019"},{"key":"10.1016\/j.lfs.2025.123637_bb0095","series-title":"WHO Consolidated Guidelines on Tuberculosis: Module 4: Treatment-Drug- Resistant Tuberculosis Treatment, 2022 Update","year":"2022"},{"key":"10.1016\/j.lfs.2025.123637_bb0100","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.2217\/epi-2017-0060","article-title":"Exploring genome-wide DNA methylation patterns in Aicardi syndrome","volume":"9","author":"Piras","year":"2017","journal-title":"Epigenomics"},{"key":"10.1016\/j.lfs.2025.123637_bb0105","article-title":"Epigenetic orchestration of host immune defences by Mycobacterium tuberculosis","volume":"273","author":"Gupta","year":"2023","journal-title":"Microbiol. Res."},{"key":"10.1016\/j.lfs.2025.123637_bb0110","doi-asserted-by":"crossref","unstructured":"A. Olsen, Y. Chen, Q. Ji, et al., Targeting Mycobacterium tuberculosis tumor necrosis factor alpha-downregulating genes for the development of antituberculous vaccines, mBio. 7(2016)e01023\u201315. doi:https:\/\/doi.org\/10.1128\/mBio.01023-15.","DOI":"10.1128\/mBio.01023-15"},{"key":"10.1016\/j.lfs.2025.123637_bb0115","doi-asserted-by":"crossref","first-page":"4836","DOI":"10.1172\/JCI67604","article-title":"MicroRNA-223 controls susceptibility to tuberculosis by regulating lung neutrophil recruitment","volume":"123","author":"Dorhoi","year":"2013","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.lfs.2025.123637_bb0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2024.156693","article-title":"Epigenetic modulation of cytokine expression in Mycobacterium tuberculosis-infected monocyte derived-dendritic cells: implications for tuberculosis diagnosis","volume":"181","author":"Meskini","year":"2024","journal-title":"Cytokine"},{"key":"10.1016\/j.lfs.2025.123637_bb0125","doi-asserted-by":"crossref","first-page":"016","DOI":"10.23937\/2378-3648\/1410016","article-title":"Understanding the host epigenetics in Mycobacterium tuberculosis infection","volume":"2","author":"Yadav","year":"2015","journal-title":"J. Genet. Genome Res."},{"key":"10.1016\/j.lfs.2025.123637_bb0130","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1038\/nrm3941","article-title":"Histone exchange, chromatin structure and the regulation of transcription","volume":"16","author":"Venkatesh","year":"2015","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.lfs.2025.123637_bb0135","doi-asserted-by":"crossref","first-page":"8922","DOI":"10.1038\/ncomms9922","article-title":"Mycobacteria modulate host epigenetic machinery by Rv1988 methylation of a non-tail arginine of histone H3","volume":"6","author":"Yaseen","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.lfs.2025.123637_bb0140","first-page":"233","article-title":"Methods for detection of NOX- derived superoxide radical anion and hydrogen peroxide in cells","volume":"2019","author":"Augsburger","year":"1982","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.lfs.2025.123637_bb0145","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s13578-018-0268-5","article-title":"Cell type-specific function of TRAF2 and TRAF3 in regulating type I IFN induction","volume":"9","author":"Xie","year":"2019","journal-title":"Cell Biosci."},{"issue":"3","key":"10.1016\/j.lfs.2025.123637_bb0150","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0151638","article-title":"CD117+ dendritic and mast cells are dependent on RasGRP4 to function as accessory cells for optimal natural killer cell-mediated responses to lipopolysaccharide","volume":"11","author":"Zhou S","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.lfs.2025.123637_bb0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.tube.2021.102077","article-title":"Immunomodulation by epigenome alterations in Mycobacterium tuberculosis infection","volume":"128","author":"Gauba","year":"2021","journal-title":"Tuberculosis"},{"issue":"12","key":"10.1016\/j.lfs.2025.123637_bb0160","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.3390\/antibiotics10121544","article-title":"DNA methyltransferase HsdM induce drug resistance on Mycobacterium tuberculosis via multiple effects","volume":"10","author":"Chu","year":"2021","journal-title":"Antibiotics"},{"issue":"1","key":"10.1016\/j.lfs.2025.123637_bb0165","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/epigenomes7010001","article-title":"Environmental adaptation of genetically uniform organisms with the help of epigenetic mechanisms- an insightful perspective on ecoepigenetics","volume":"7","author":"Vogt","year":"2023","journal-title":"Epigenomes"},{"key":"10.1016\/j.lfs.2025.123637_bb0170","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1007\/s11274-019-2733-7","article-title":"Aberrant methylation of host macrophages by tuberculosis infection","volume":"35","author":"Behrouzi","year":"2019","journal-title":"World J. Microbiol. Biotechnol."},{"issue":"2","key":"10.1016\/j.lfs.2025.123637_bb0175","first-page":"87","article-title":"Developing DNA methylation-based diagnostic biomarkers","volume":"45","author":"Kim","year":"2018","journal-title":"J. Genomics."},{"key":"10.1016\/j.lfs.2025.123637_bb0180","doi-asserted-by":"crossref","first-page":"3113","DOI":"10.1172\/JCI134622","article-title":"DNA hypermethylation during tuberculosis dampens host immune responsiveness","volume":"130","author":"Rajapakshe","year":"2020","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.lfs.2025.123637_bb0185","doi-asserted-by":"crossref","first-page":"12849","DOI":"10.1038\/ncomms12849","article-title":"PARP9 and PARP14 cross-regulate macrophage activation via STAT1 ADP-ribosylation","volume":"7","author":"Iwata","year":"2016","journal-title":"Nat. Commun."},{"issue":"4","key":"10.1016\/j.lfs.2025.123637_bb0190","first-page":"1943","article-title":"Histone H3K14 hypoaceylation and H3K27 hypermethylation along with HDAC1 up-regulation and KDM6B down-regulation are associated with active pulmonary tuberculosis disease","volume":"9","author":"Chen","year":"2017","journal-title":"Am. J. Transl. Res."},{"issue":"2","key":"10.1016\/j.lfs.2025.123637_bb0195","first-page":"265","article-title":"Hypothetical protein Rv3423.1 of Mycobacterium tuberculosis is a histone acetyltransferase, FEBS","volume":"283","author":"Jose","year":"2016","journal-title":"J"},{"key":"10.1016\/j.lfs.2025.123637_bb0200","doi-asserted-by":"crossref","unstructured":"R. E. Maphasa, M. Meyer, A. Dube, 2021. The macrophage response toMycobacterium tuberculosis and opportunities for autophagy inducingnanomedicines for tuberculosis therapy. Front. Cell Infect. Microbiol. 10, 618414. doi:https:\/\/doi.org\/10.3389\/fcimb.2020.618414.","DOI":"10.3389\/fcimb.2020.618414"},{"issue":"12","key":"10.1016\/j.lfs.2025.123637_bb0205","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1001230","article-title":"Mycobacterium tuberculosis Eis regulates autophagy, inflammation, and cell death through redox-dependent signalling","volume":"6","author":"Shin","year":"2010","journal-title":"PLoS Pathog."},{"issue":"3","key":"10.1016\/j.lfs.2025.123637_bb0210","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1515\/bmc.2011.017","article-title":"Epigenetic regulation of matrix metalloprotease and their collagen substrates in cancer","volume":"2","author":"Chernov","year":"2011","journal-title":"Biomol. Concepts"},{"issue":"10","key":"10.1016\/j.lfs.2025.123637_bb0215","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1634\/theoncologist.12-10-1247","article-title":"FDA approval summary: Vorinostat for the treatment of advanced primary cutaneous T-cell lymphoma","volume":"12","author":"Mann","year":"2007","journal-title":"Oncol"},{"key":"10.1016\/j.lfs.2025.123637_bb0220","doi-asserted-by":"crossref","first-page":"1027472","DOI":"10.3389\/fimmu.2022.1027472","article-title":"MicroRNAs as immune regulators and biomarkers in tuberculosis","volume":"13","author":"Wang","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.lfs.2025.123637_bb0225","doi-asserted-by":"crossref","first-page":"1009901","DOI":"10.3389\/fcimb.2022.1009901","article-title":"microRNAs associated with the pathogenesis and their role in regulating various signaling pathways during Mycobacterium tuberculosis infection","volume":"12","author":"Davuluri","year":"2022","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.lfs.2025.123637_bb0230","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2020.173529","article-title":"MiRNAs in tuberculosis: their decisive role in the fate of TB","volume":"886","author":"Alipoor","year":"2020","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.lfs.2025.123637_bb0235","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.molimm.2015.08.006","article-title":"miR-223 is upregulated in monocytes from patients with tuberculosis and regulates function of monocyte-derived macrophages","volume":"67","author":"Liu","year":"2015","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.lfs.2025.123637_bb0240","doi-asserted-by":"crossref","unstructured":"G. Zhang, X. Liu, W. Wang, et al., Down-regulation of miR-20a-5p triggers cell apoptosis to facilitate mycobacterial clearance through targeting JNK2 in human macrophages, Cell Cycle 15 (20160 2527\u20132538. doi:https:\/\/doi.org\/10.1080\/15384101.2016.1215386.","DOI":"10.1080\/15384101.2016.1215386"},{"key":"10.1016\/j.lfs.2025.123637_bb0245","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.687962","article-title":"The role of microRNAs and long non-coding RNAs in the regulation of the immune response to Mycobacterium tuberculosis infection","volume":"12","author":"Kundu","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.lfs.2025.123637_bb0250","first-page":"1654","article-title":"MicroRNA-144-3p inhibits host lipid catabolism and autophagy by targeting PPAR\u03b1 and ABCA1 during Mycobacterium tuberculosis infection, ACS","volume":"10;10(5)","author":"Wu","year":"2024","journal-title":"Infect. Dis."},{"issue":"4","key":"10.1016\/j.lfs.2025.123637_bb0255","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1161\/ATVBAHA.113.302701","article-title":"MicroRNA-155 deficiency results in decreased macrophage inflammation and attenuated atherogenesis in apolipoprotein E- deficient mice","volume":"34","author":"Du","year":"2014","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"6","key":"10.1016\/j.lfs.2025.123637_bb0260","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1038\/ni.3434","article-title":"Mycobacterium tuberculosis induces the miR-33 locus to reprogram autophagy and host lipid metabolism","volume":"17","author":"Ouimet","year":"2016","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.lfs.2025.123637_bb0265","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s41544-019-0040-y","article-title":"The role of host miRNAs on Mycobacterium tuberculosis","volume":"1","author":"Behrouzi","year":"2019","journal-title":"ExRNA"},{"key":"10.1016\/j.lfs.2025.123637_bb0270","doi-asserted-by":"crossref","unstructured":"F. Mukhtar, F.,A. Guarnieri, N. Brancazio, et al., 2024. The role of Mycobacterium tuberculosis exosomal miRNAs in host pathogen cross-talk as diagnostic and therapeutic biomarkers. Front. Microbiol. 15, 1441781. doi:https:\/\/doi.org\/10.3389\/fmicb.2024.1441781.","DOI":"10.3389\/fmicb.2024.1441781"},{"issue":"1","key":"10.1016\/j.lfs.2025.123637_bb0275","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1186\/s12967-017-1205-9","article-title":"Bovis Bacillus Calmette- Guerin (BCG) infection induces exosomal miRNA release by human macrophages","volume":"15","author":"Alipoor","year":"2017","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.lfs.2025.123637_bb0280","doi-asserted-by":"crossref","unstructured":"L. Lai, K. M. Azzam, W. C. et al., MicroRNA-33 regulates the innate immune response via ATP binding cassette transporter-mediated remodeling of membrane microdomains, J. Biol. Chem. 291(37) (2016) 19651\u201360. doi:https:\/\/doi.org\/10.1074\/jbc.M116.723056.","DOI":"10.1074\/jbc.M116.723056"},{"issue":"12","key":"10.1016\/j.lfs.2025.123637_bb0285","first-page":"443","article-title":"The ATP-binding cassette (ABC) transport systems in Mycobacterium tuberculosis: structure, function, and possible targets for therapeutics","volume":"9","author":"de Oliveira","year":"2020","journal-title":"Biology (Basel)."},{"key":"10.1016\/j.lfs.2025.123637_bb0290","doi-asserted-by":"crossref","first-page":"1290227","DOI":"10.3389\/fmicb.2024.1290227","article-title":"Identification of positively selected genes in Mycobacterium tuberculosis from southern Xinjiang Uygur autonomous region of China","volume":"15","author":"Deng","year":"2024","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.lfs.2025.123637_bb0295","article-title":"Associations of genetic variants of miRNA coding regions with pulmonary tuberculosis risk in China","volume":"149","author":"Zhang","year":"2021","journal-title":"Epidemiol. Infect."},{"key":"10.1016\/j.lfs.2025.123637_bb0300","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2020.01631","article-title":"SncRNA-1 is a small noncoding RNA produced by Mycobacterium tuberculosis in infected cells that positively regulates genes coupled to oleic acid biosynthesis","volume":"11","author":"Coskun","year":"2020","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.lfs.2025.123637_bb0305","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1005641","article-title":"Leaderless transcripts and small proteins are common features of the mycobacterial translational landscape","volume":"11","author":"Shell","year":"2015","journal-title":"PLoS Genet."},{"key":"10.1016\/j.lfs.2025.123637_bb0310","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.tube.2016.10.007","article-title":"Levels of microRNA miR-16 and miR-155 are altered in serum of patients with tuberculosis and associate with responses to therapy","volume":"102","author":"Wagh","year":"2017","journal-title":"Tuberculosis (Edinb.)"},{"key":"10.1016\/j.lfs.2025.123637_bb0315","doi-asserted-by":"crossref","unstructured":"E. A. Daniel, B. Sathiyamani, K, 2022. Thiruvengadam, et al. MicroRNAs as diagnostic biomarkers for tuberculosis: a systematic review and meta- analysis. Front. Immunol. 13, 954396. doi:https:\/\/doi.org\/10.3389\/fimmu.2022.954396.","DOI":"10.3389\/fimmu.2022.954396"},{"key":"#cr-split#-10.1016\/j.lfs.2025.123637_bb0320.1","doi-asserted-by":"crossref","unstructured":"B. Pattnaik, N. Patnaik, S. Mittal, et al. Micro RNAs as potential biomarkers in tuberculosis: A systematic review. Noncoding RNA Res. 2022 Jan 1;7","DOI":"10.1016\/j.ncrna.2021.12.005"},{"key":"#cr-split#-10.1016\/j.lfs.2025.123637_bb0320.2","doi-asserted-by":"crossref","unstructured":"(1) (2022)16-26. doi:https:\/\/doi.org\/10.1016\/j.ncrna.2021.12.005.","DOI":"10.1016\/j.ncrna.2021.12.005"},{"issue":"2","key":"10.1016\/j.lfs.2025.123637_bb0325","doi-asserted-by":"crossref","first-page":"369","DOI":"10.3390\/diagnostics12020369","article-title":"Identification of microRNAs as potential blood-based biomarkers for diagnosis and therapeutic monitoring of active tuberculosis","volume":"12","author":"Kim","year":"2022","journal-title":"Diagnostics (Basel)."},{"key":"10.1016\/j.lfs.2025.123637_bb0330","doi-asserted-by":"crossref","first-page":"1197805","DOI":"10.3389\/fimmu.2023.1197805","article-title":"Downregulation of monocyte miRNAs: implications for immune dysfunction and disease severity in drug-resistant tuberculosis","volume":"14","author":"Sampath","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.lfs.2025.123637_bb0335","doi-asserted-by":"crossref","first-page":"333","DOI":"10.2147\/IDR.S144446","article-title":"Diversity and evolution of drug resistance mechanisms in Mycobacterium tuberculosis","volume":"10","author":"Al-Saeedi","year":"2017","journal-title":"Infect. Drug. Resist."},{"key":"10.1016\/j.lfs.2025.123637_bb0340","doi-asserted-by":"crossref","DOI":"10.1128\/IAI.00649-19","article-title":"Unraveling the role of microRNAs in Mycobacterium tuberculosis infection and disease: advances and pitfalls","volume":"88","author":"Ruiz-Tagle","year":"2020","journal-title":"Infect. Immun."},{"issue":"6","key":"10.1016\/j.lfs.2025.123637_bb0345","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1111\/jam.14478","article-title":"Recent updates on drug resistance in Mycobacterium tuberculosis due to antibiotic selection pressure","volume":"128","author":"Singh","year":"2020","journal-title":"J. Appl. Microbiol."},{"issue":"12","key":"10.1016\/j.lfs.2025.123637_bb0350","first-page":"443","article-title":"The ATP-binding cassette (ABC) tTransport systems in Mycobacterium tuberculosis: structure, function, and possible targets for therapeutics","volume":"9","author":"Balan","year":"2020","journal-title":"Biology (Basel)."},{"key":"10.1016\/j.lfs.2025.123637_bb0355","doi-asserted-by":"crossref","first-page":"D320","DOI":"10.1093\/nar\/gkw1068","article-title":"Transport DB 2.0: a database for exploring membrane transporters in sequenced genomes from all domains of life","volume":"45","author":"Elbourne","year":"2017","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.lfs.2025.123637_bb0360","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1007\/s00284-012-0215-3","article-title":"The expression of ABC efflux pump, Rv1217c-Rv1218c, and its association with multidrug resistance of Mycobacterium tuberculosis in China","volume":"66","author":"Wang","year":"2013","journal-title":"Curr. Microbiol."},{"key":"10.1016\/j.lfs.2025.123637_bb0365","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.celrep.2019.12.015","article-title":"Mycobacterium tuberculosis limits host glycolysis and IL-1beta by restriction of PFK-M via MicroRNA-21","volume":"30","author":"Hackett","year":"2020","journal-title":"Cell Rep."},{"key":"10.1016\/j.lfs.2025.123637_bb0370","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1007\/s00204-016-1727-6","article-title":"Antibiotic resistance mechanisms in M. Tuberculosis: an update","volume":"90","author":"Nguyen","year":"2016","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.lfs.2025.123637_bb0375","first-page":"4920209","article-title":"Nanotechnology-based approach in tuberculosis treatment","volume":"2017","author":"Nasiruddin","year":"2017","journal-title":"Tuberc. Res. Treat."},{"issue":"11","key":"10.1016\/j.lfs.2025.123637_bb0380","article-title":"Strategies to overcome the action of aminoglycoside-modifying enzymes for treating resistant bacterial infections. Future","volume":"5","author":"Labby","year":"2013","journal-title":"Med. Chem."},{"key":"10.1016\/j.lfs.2025.123637_bb0385","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.drup.2010.08.003","article-title":"Aminoglycoside modifying enzymes","volume":"13","author":"Ramirez","year":"2010","journal-title":"Drug Resist. Updat."},{"issue":"2017","key":"10.1016\/j.lfs.2025.123637_bb0390","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1093\/femsre\/fux011","article-title":"Antimicrobial resistance in Mycobacterium tuberculosis: mechanistic and evolutionary perspectives","volume":"41","author":"Gygli","year":"2017","journal-title":"FEMS Microbiol. Rev."},{"key":"10.1016\/j.lfs.2025.123637_bb0395","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/microbiolspec.VMBF-0016-2015","article-title":"Mechanisms of antibiotic resistance","volume":"4","author":"Munita","year":"2016","journal-title":"Microbiol. Spectr."},{"key":"10.1016\/j.lfs.2025.123637_bb0400","doi-asserted-by":"crossref","first-page":"2370","DOI":"10.1093\/nar\/gks1351","article-title":"Mycobacterium fluoroquinolone resistance protein B, a novel small GTPase is involved in the regulation of DNA gyrase and drug resistance","volume":"41","author":"Tao","year":"2013","journal-title":"Nucleic Acids Res."},{"issue":"14","key":"10.1016\/j.lfs.2025.123637_bb0405","doi-asserted-by":"crossref","first-page":"4172","DOI":"10.1111\/febs.16170","article-title":"Epigenetic code during mycobacterial infections: therapeutic implications for tuberculosis","volume":"289","author":"Fatima","year":"2022","journal-title":"FEBS J."},{"key":"10.1016\/j.lfs.2025.123637_bb0410","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1038\/nrm3931","article-title":"50 years of protein acetylation: from gene regulation to epigenetics, metabolism and beyond","volume":"16","author":"Verdin","year":"2015","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.lfs.2025.123637_bb0415","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.55415","article-title":"Host sirtuin 2 as an immunotherapeutic target against tuberculosis","volume":"9","author":"Bhaskar","year":"2020","journal-title":"eLife"},{"key":"10.1016\/j.lfs.2025.123637_bb0420","doi-asserted-by":"crossref","DOI":"10.7150\/ijbs.13805","article-title":"A group of novel serum diagnostic biomarkers for multidrug-resistant tuberculosis by iTRAQ-2D LC-MS\/MS and solexa sequencing","volume":"12","author":"Wang","year":"2016","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.lfs.2025.123637_bb0425","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.760468","article-title":"A dual marker for monitoring MDR-TB treatment: host-derived miRNAs and M. Tuberculosis- derived RNA sequences in serum","volume":"12","author":"Carranza","year":"2021","journal-title":"Front. Immunol."},{"issue":"10","key":"10.1016\/j.lfs.2025.123637_bb0430","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.3390\/ph16101428","article-title":"Functionalizing dendrimers for targeted delivery of bioactive molecules to macrophages: a potential treatment for Mycobacterium tuberculosis infection- a review","volume":"16","author":"Sanhueza","year":"2023","journal-title":"Pharmaceuticals (Basel)"},{"key":"10.1016\/j.lfs.2025.123637_bb0435","doi-asserted-by":"crossref","first-page":"356","DOI":"10.3390\/antibiotics11030356","article-title":"Understanding microRNAs in the context of infection to find new treatments against human bacterial pathogens","volume":"11","author":"Mourenza","year":"2022","journal-title":"Antibiotics"},{"issue":"12","key":"10.1016\/j.lfs.2025.123637_bb0440","article-title":"Monocyte and macrophage miRNA: potent biomarker and target for host-directed therapy for tuberculosis","volume":"2021","author":"Sampath","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.lfs.2025.123637_bb0445","doi-asserted-by":"crossref","unstructured":"A.A. Patel, K. Cahill, C. Saygin C, et al., Cedazuridine\/decitabine: frompreclinical to clinical development in myeloid malignancies, Blood Adv 2021;5(8) (2021) 2264\u20132271.","DOI":"10.1182\/bloodadvances.2020002929"},{"issue":"1","key":"10.1016\/j.lfs.2025.123637_bb0450","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s10020-021-00296-1","article-title":"The emerging role of exosomal miRNAs as a diagnostic and therapeutic biomarker in Mycobacterium tuberculosis infection","volume":"27","author":"Mirzaei","year":"2021","journal-title":"Mol. Med."},{"issue":"8","key":"10.1016\/j.lfs.2025.123637_bb0455","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.2217\/epi-2018-0028","article-title":"Integrated miRNA and mRNA expression profiling to identify mRNA targets of dysregulated miRNAs in pulmonary tuberculosis","volume":"10","author":"Zhang","year":"2018","journal-title":"Epigenomics"},{"key":"10.1016\/j.lfs.2025.123637_bb0460","first-page":"168","article-title":"MicroRNAs as therapeutics for future drug delivery systems in treatment of lung diseases, drug Delivd","volume":"7","author":"Dua","year":"2017","journal-title":"Transl. Res."},{"issue":"10","key":"10.1016\/j.lfs.2025.123637_bb0465","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.3390\/vaccines10101740","article-title":"Epigenetics in tuberculosis: immunomodulation of host immune response","volume":"10","author":"Khadela","year":"2022","journal-title":"vaccines"}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320525002723?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320525002723?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,22]],"date-time":"2025-05-22T16:35:22Z","timestamp":1747931722000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0024320525002723"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":94,"alternative-id":["S0024320525002723"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2025.123637","relation":{},"ISSN":["0024-3205"],"issn-type":[{"value":"0024-3205","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A review of the human microRNA and the Mycobacterium tuberculosis epigenetic effects on the emergence drug resistance","name":"articletitle","label":"Article Title"},{"value":"Life Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lfs.2025.123637","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"123637"}}